SCHEMBL7349601

SCHEMBL7349601

NC(=O)CC(NC(=O)c1ccc2ncccc2c1)C(N)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.60
TAS1R1 Q7RTX1 1/20 0.60
PLK1 P53350 1/20 0.56
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
ALOX15 P16050 1/20 0.50
HTT P42858 1/20 0.50
BCAT1 P54687 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.47
ALDH1A1 P00352 3/20 0.46
RAB9A P51151 3/20 0.46
GAA P10253 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 2/20 0.46
MAPT P10636 1/20 0.46
ADAM17 P78536 1/20 0.46
LMNA P02545 1/20 0.46
DOT1L Q8TEK3 1/20 0.45
POLB P06746 1/20 0.44
PABPC1 P11940 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7349608 1.00 TAS1R3 (0.60) TAS1R3TAS1R1PLK1HDAC1HDAC2
SCHEMBL7340288 0.92 TAS1R3 (0.59) TAS1R3TAS1R1PLK1HDAC1HDAC2
SCHEMBL3492806 0.79 PLK1 (0.72) TAS1R3TAS1R1PLK1HDAC1HDAC2
SCHEMBL31419202 0.79 PLK1 (0.72) TAS1R3TAS1R1PLK1HDAC1HDAC2
SCHEMBL4165636 0.77 TAS1R3 (0.79) TAS1R3TAS1R1PLK1HDAC1HDAC2
SCHEMBL9749106 0.76 PLK1 (0.73) TAS1R3TAS1R1PLK1HDAC1HDAC2
SCHEMBL7330575 0.76 MGAM (0.52) BCAT1CCR1
SCHEMBL4203545 0.75 TAS1R3 (1.00) TAS1R3TAS1R1PLK1ALOX15HTT
SCHEMBL4203543 0.75 TAS1R3 (1.00) TAS1R3TAS1R1PLK1ALOX15HTT
SCHEMBL703553 0.75 PLK1 (0.63) TAS1R3TAS1R1PLK1HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005448-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS Du Pont Pharmaceuticals Company (US) 2000-06-07 EP disclosed
WO-1999009000-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS DU PONT PHARMACEUTICALS COMPANY (US) 1999-02-25 WO disclosed